Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma

Published:2017-12 Issue:6 Volume:56 Page:814-818
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Dogu Mehmet Hilmi,Çagirgan Seçkin,Ocakci Serkan,Kaya Ali Hakan,Ilkkilic Kadir,Sanli Neslihan Mandaci,Kahraman Selda,Eren Rafet,Tekgunduz Emre,Hacioglu Sibel,Kaynar Leylagul,Erkurt Mehmet Ali,Altuntas Fevzi

Publisher

Elsevier BV

Subject

Hematology

Reference32 articles.

1. Future of cancer incidence in the United States: burdens upon an aging, changing nation;Smith;J Clin Oncol,2009

2. Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age;Stamatoullas;Bone Marrow Transplant,1997

3. Peripheral blood stem cell transplantationasfront-line therapy in patients aged 61 to 65 years: a pilot study;Moreau;Bone Marrow Transplant,1998

4. Autologous blood and marrow transplantation in patients 0 years and older;Leger;Biol Blood Marrow Transplant,2000

5. Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients ( >/= 60 years) with nonHodgkin’s lymphoma: comparison with patients <60 years treated within the same protocol;Jantunen;Bone Marrow Transplant,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-examining the role of hematopoietic stem cell transplantation in relapsed large B-cell lymphoma in the era of chimeric antigen receptor (CAR) T-cell therapy;Frontiers in Oncology;2024-08-15

2. Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation;Annals of Transplantation;2021-09-13

3. Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience;TURKISH JOURNAL OF MEDICAL SCIENCES;2021-04-30